Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_assertion description "[Lansoprazole (LPZ), amoxicillin (AMPC) and clarithromycin (CAM) are commonly used drugs (LAC regimen) for Helicobacter pylori (H. pylori) eradication, but the eradication rate with this regimen was reported to be 70% to 90%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_assertion evidence source_evidence_literature NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_assertion SIO_000772 21614934 NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_assertion wasDerivedFrom befree-20140225 NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_assertion wasGeneratedBy ECO_0000203 NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP474410.RAsTzDtq_6LS4siStYztvjw4nIJFYaD59kDv6ACTRVwzA130_provenance.